PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.00
Bid: 240.00
Ask: 260.00
Change: 0.00 (0.00%)
Spread: 20.00 (8.333%)
Open: 250.00
High: 250.00
Low: 250.00
Prev. Close: 250.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

Mon, 18th Jan 2021 10:41

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

----------

AIM WINNERS

----------

CPPGroup, up 46% at 478.00 pence. The insurance and financial services company said earnings for 2020 are expected to surpass market consensus, with the firm expecting 2020 earnings before interest, tax, depreciation, and amortization of between GBP7.1 million to GBP7.3 million, ahead of market forecasts of GBP6.4 million.

----------

Faron Pharmaceuticals, up 22% at 337.56 pence. The biopharmaceutical said the US Department of Defense has chosen the HIBISCUS Study to receive USD6.1 million of funding from the Coronavirus Aid, Relief & Economic Security Act. The phase II/III HIBISCUS trial will assess Traumakine, Faron's IV IFN beta-1a, for the treatment of hospitalised Covid-19 patients in the US.

----------

Mosman Oil & Gas, up 22% at 0.214 pence. The Australia and US-focused oil and gas explorer confirmed the completion of the sale of the Welch Project, in Texas, for USD420,000.

----------

Augean, up 10% at 206.25 pence. The waste management company said it expects to report an adjusted pretax profit for 2020 at least in line with the year before, despite the decline of its North Sea business and the ongoing Covid-19 pandemic. In 2019, Augean's adjusted pretax profit was GBP19.2 million.

----------

AIM LOSERS

----------

Velocys, down 26% at 7.64 pence. The sustainable fuels technology company said Shell International Petroleum has withdrawn from the Altalto Joint Development agreement. Velocys and British Airways will continue to work to secure finance for the Altalto Immingham plant, and will continue talks with potential finance sources.

----------

SEC Newgate, down 12% at 42.50 pence. The public relations firm said its two largest UK agencies, SEC Newgate UK - Newgate Communications - and Newington Communications, will merge and rebrand as SEC Newgate UK. As part of this, SEC Newgate will increase its stake in Newington to 100% from 60%, paying GBP420,799 for the 40% minority stake it did not already own.

----------

Remote Monitored Systems, down 8.7% at 2.74 pence. The data collection and surveying firm said the last test for its 4-ply mask, the biocompatibility test, has been delayed and is now expected to be completed in the next week. The mask manufacturing machine arrived from Lemu, as expected, and has been installed in Nottingham's BioCity, with work beginning this week to commission the machine and commence production.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Nov 2019 17:59

Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress

Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress

Read more
1 Nov 2019 16:58

LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week

LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week

Read more
1 Nov 2019 15:32

Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge

Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge

Read more
9 Oct 2019 14:05

Faron Pharmaceuticals positive on feedback from 'Clevegen' monitoring committee

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced feedback from the 'MATINS' study data monitoring committee on Wednesday, from the ongoing dose escalation study from part 1 of the MATINS trial.

Read more
9 Oct 2019 09:18

Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study

Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study

Read more
2 Oct 2019 14:57

Faron Pharmaceuticals hits bump in road for Traumakine manufacturing

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that, further to its update in its interim results in relation to the active pharmaceutical ingredient (API) manufacturing process for 'Traumakine', Rentschler Biopharma has sent Faron a letter in which it terminated the agreement concerning the API manufacturing.

Read more
2 Oct 2019 13:13

Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals

Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals

Read more
23 Sep 2019 11:37

Faron Pharmaceuticals Ends Traumakine Trial; Loss Narrows On Expenses

(Alliance News) - Faron Pharmaceuticals Oy on Monday said its loss narrowed considerably in the first half of 2019, after it cut back on research & development spending and opted to end a firm

Read more
16 Sep 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 17 September JTCHalf Year ResultsStafflineHalf Year GroupHalf Year Year

Read more
27 Aug 2019 16:34

Faron Pharma raises ?2.3m to keep it going through the start of 2020

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has received valid acceptances and excess applications from qualifying shareholders for a total of 859,513 open offer shares, raising gross proceeds of around €1.01m (£0.92m) at the issue price of 106p per share and at the euro issue price of 119 cents per share, it announced on Tuesday.

Read more
27 Aug 2019 11:38

Faron Pharma Raises EUR2.5 Million; Now Has Working Capital To 2020

(Alliance News) - Faron Pharmaceuticals Oy on Tuesday said it has raised EUR2.5 million via share subscription and open offer.The company raised EUR1.0 million from the issue of 859,513 at

Read more
5 Aug 2019 12:26

Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development

(Alliance News) - Faron Pharmaceuticals Oy on Monday announced a EUR1.1 million subscription and EUR2.0 million open offer to fund the clinical development of cancer drug Clevegen.Shares in

Read more
12 Jul 2019 10:35

WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------BHP up 1.5%. The -

Read more
12 Jul 2019 10:20

Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity

(Alliance News) - Faron Pharmaceuticals Oy said on Friday its MATINS study of nine cancer patients is progressing well, and it is planning to expand the clinical trial to more countries.The

Read more
26 Jun 2019 11:52

Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use

(Alliance News) - Faron Pharmaceuticals Oy on Wednesday said interim results from its phase two Inforaaa study support continuation but the study is limited by a lack of patients not also taking a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.